Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.40
-0.3300-4.27%
Volume:107.13K
Turnover:793.87K
Market Cap:258.34M
PE:7.73
High:7.62
Open:7.62
Low:7.32
Close:7.73
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:1.05
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.13
PE(LYR):7.71

Loading ...

Tredegar CFO Frasier Brickhouse to Retire Effective Sept. 1, 2026

Reuters
·
Jul 31

Tredegar Announces the Retirement of Frasier W. Brickhouse Ii, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026

THOMSON REUTERS
·
Jul 31

This TG Metals Insider Reduced Their Stake By 100%

Simply Wall St.
·
Jul 29

TG Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jul 28

B. Riley Raises Price Target on TG Therapeutics to $86 From $55, Keeps Buy Rating

MT Newswires Live
·
Jul 27

Medallion Metals, TG Metals Sign Ore Processing Agreement for Van Uden Gold Stockpiles

MT Newswires Live
·
Jul 22

TG Metals Strikes Profit-Share Ore Deal for Van Uden Stockpiles

TIPRANKS
·
Jul 22

Medallion Metals strikes profit-share processing deal with TG Metals

TIPRANKS
·
Jul 22

Analyst Tara Bancroft Raises TG Therapeutics Price Target to $75 on Strong Long-Term Briumvi Growth Outlook

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), McKesson (MCK) and TG Therapeutics (TGTX)

TIPRANKS
·
Jul 22

TG Therapeutics Targets Myasthenia Gravis Growth With New BRIUMVI Trial

TIPRANKS
·
Jul 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 16

Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and TG Therapeutics (TGTX)

TIPRANKS
·
Jul 14

TG Therapeutics (TGTX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Jul 13

TG Therapeutics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 13

TG Metals Drilling Expands Laterite Gold Potential at Van Uden

TIPRANKS
·
Jul 09

Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says

MT Newswires Live
·
Jul 07

BofA Securities Adjusts Price Target on TG Therapeutics to $20 From $17, Maintains Underperform Rating

MT Newswires Live
·
Jul 07

TG Therapeutics price target raised to $20 from $17 at BofA

TIPRANKS
·
Jul 07

TG Therapeutics Price Target Maintained with a $70.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 07